The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Review of Safety and Efficacy of Sleep Medicines in Older Adults
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of insomnia: what we know and what we still need to learn
Ohayon, M. M. (2002) · Sleep Medicine Reviews · doi:10.1053/smrv.2002.0186 · Cited by 3,743
Ohayon, M. M., Carskadon, M. A., Guilleminault, C., & Vitiello, M. V. (2004) · Sleep · doi:10.1093/sleep/27.7.1255 · Cited by 3,349
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03923.x · Cited by 2,578
Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?
Ford, D. E. (1989) · JAMA · doi:10.1001/jama.262.11.1479 · Cited by 2,440
Pharmacotherapy: A Pathophysiologic Approach
(1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-5-447_3 · Cited by 2,407
Epidemiologic Study of Sleep Disturbances and Psychiatric Disorders: An Opportunity for Prevention?
Ford, D. E. (1989) · JAMA · doi:10.1001/jama.1989.03430110069030 · Cited by 2,252
Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., Denberg, T. D., & for the Clinical Guidelines Committee of the American College of Physicians* (2016) · Annals of Internal Medicine · doi:10.7326/m15-2175 · Cited by 1,965
Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults
Schutte-Rodin, S., Broch, L., Buysse, D., Dorsey, C., & Sateia, M. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27286 · Cited by 1,943
Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits
Glass, J., Lanctôt, K. L., Herrmann, N., Sproule, B. A., & Busto, U. E. (2005) · BMJ · doi:10.1136/bmj.38623.768588.47 · Cited by 1,161
Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis
Trauer, J. M., Qian, M. Y., Doyle, J. S., Rajaratnam, S. M. W., & Cunnington, D. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2841 · Cited by 1,053
An American Academy of Sleep Medicine Report, Morgenthaler, T., Kramer, M., Alessi, C., Friedman, L., Boehlecke, B., Brown, T., Coleman, J., Kapur, V., Lee-Chiong, T., et al. (2006) · Sleep · doi:10.1093/sleep/29.11.1415 · Cited by 835
Morin, C. M., Vallières, A., Guay, B., Ivers, H., Savard, J., Mérette, C., Bastien, C., & Baillargeon, L. (2009) · JAMA · doi:10.1001/jama.2009.682 · Cited by 791
Benzodiazepine Use in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1763 · Cited by 786
A new benzodiazepine pharmacology
Möhler, H., Fritschy, J. M., & Rudolph, U. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.2 · Cited by 716
Benzodiazepine pharmacology and central nervous system-mediated effects.
(2013) · Europe PMC (PubMed Central) · Cited by 650
Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review
Mitchell, M. D., Gehrman, P., Perlis, M., & Umscheid, C. A. (2012) · BMC Family Practice · doi:10.1186/1471-2296-13-40 · Cited by 617
Meta-analysis of benzodiazepine use in the treatment of insomnia.
(2000) · PubMed Central · Cited by 613
Maher, A. R., Maglione, M., Bagley, S., Suttorp, M., Hu, J.-H., Ewing, B., Wang, Z., Timmer, M., Sultzer, D., & Shekelle, P. G. (2011) · JAMA · doi:10.1001/jama.2011.1360 · Cited by 558
Benzodiazepines of Long and Short Elimination Half-life and the Risk of Hip Fracture
Ray, W. A. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430230088031 · Cited by 548
Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist
Kato, K., Hirai, K., Nishiyama, K., Uchikawa, O., Fukatsu, K., Ohkawa, S., Kawamata, Y., Hinuma, S., & Miyamoto, M. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.09.007 · Cited by 539
Michelson, D., Snyder, E., Paradis, E., Chengan-Liu, M., Snavely, D. B., Hutzelmann, J., Walsh, J. K., Krystal, A. D., Benca, R. M., Cohn, M., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70053-5 · Cited by 519
Association Between Nutritional Status and Cognitive Functioning in a Healthy Elderly Population
Goodwin, J. S. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1983.03330450047024 · Cited by 495
Improvement of sleep quality in elderly people by controlled-release melatonin
Garfinkel, D., Laudon, M., Nof, D., & Zisapel, N. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91382-3 · Cited by 474
Medical and socio-professional impact of insomnia
Léger, D., Guilleminault, C., Bader, G., Lévy, E., & Paillard, M. (2002) · Sleep · doi:10.1093/sleep/25.6.621 · Cited by 468
Quality of life in people with insomnia.
Zammit, G. K., Weiner, J., Damato, N., Sillup, G. P., & McMillan, C. A. (1999) · PubMed · Cited by 467
The diagnosis and management of benzodiazepine dependence
Ashton, H. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000165594.60434.84 · Cited by 455
Gottesmann, C. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00034-9 · Cited by 439
An efficacy, safety, and dose–response study of Ramelteon in patients with chronic primary insomnia
ERMAN, M., SEIDEN, D., ZAMMIT, G., SAINATI, S., & ZHANG, J. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2005.09.004 · Cited by 434
Psychoactive Drugs and the Risk of Injurious Motor Vehicle Crashes in Elderly Drivers
Ray, W. A., Fought, R. L., & Decker, M. D. (1992) · American Journal of Epidemiology · doi:10.1093/aje/136.7.873 · Cited by 417
The morbidity of insomnia uncomplicated by psychiatric disorders
Weissman, M. M., Greenwald, S., Niño-Murcia, G., & Dement, W. C. (1997) · General Hospital Psychiatry · doi:10.1016/s0163-8343(97)00056-x · Cited by 415
Hypnotics' association with mortality or cancer: a matched cohort study
Kripke, D. F., Langer, R. D., & Kline, L. E. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-000850 · Cited by 408
A Multicenter, Placebo-controlled Trial of Melatonin for Sleep Disturbance in Alzheimer's Disease
Singer, C., Tractenberg, R. E., Kaye, J., Schafer, K., Gamst, A., Grundman, M., Thomas, R., & Thal, L. J. (2003) · Sleep · doi:10.1093/sleep/26.7.893 · Cited by 407
Hajak, G., Müller, W. E., Wittchen, H. U., Pittrow, D., & Kirch, W. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00491.x · Cited by 404
Involuntary Weight Loss in Older Outpatients: Incidence and Clinical Significance
Wallace, J. I., Schwartz, R. S., LaCroix, A. Z., Uhlmann, R. F., & Pearlman, R. A. (1995) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1995.tb05803.x · Cited by 402
Benzodiazepine Use and the Risk of Motor Vehicle Crash in the Elderly
Hemmelgarn, B. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550010041037 · Cited by 395
Sleep Problems as a Risk Factor for Falls in a Sample of Community‐Dwelling Adults Aged 64–99 years
Brassington, G. S., King, A. C., & Bliwise, D. L. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb02596.x · Cited by 351
Major Depressive Disorder Treatment Guidelines in America and Europe
Davidson, J. R. T. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.9058se1c.04gry · Cited by 344
Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Adults with Primary Insomnia
Roth, T., Rogowski, R., Hull, S., Schwartz, H., Koshorek, G., Corser, B., Seiden, D., & Lankford, A. (2007) · Sleep · doi:10.1093/sleep/30.11.1555 · Cited by 338
Risk factors for sleep disturbances in older adults: Evidence from prospective studies
Smagula, S. F., Stone, K. L., Fabio, A., & Cauley, J. A. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2015.01.003 · Cited by 335
White, H., Pieper, C., & Schmader, K. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb04537.x · Cited by 323
Zolpidem: A Review of Its Use in the Management of Insomnia
Swainston Harrison, T., & Keating, G. M. (2005) · CNS Drugs · doi:10.2165/00023210-200519010-00008 · Cited by 323
Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant
Herring, W. J., Snyder, E., Budd, K., Hutzelmann, J., Snavely, D., Liu, K., Lines, C., Roth, T., & Michelson, D. (2012) · Neurology · doi:10.1212/wnl.0b013e31827688ee · Cited by 322
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
Holm, K. J., & Goa, K. L. (2000) · Drugs · doi:10.2165/00003495-200059040-00014 · Cited by 317
Sleep disorders and melatonin rhythms in elderly people
Haimov, I., Laudon, M., Zisapel, N., Souroujon, M., Nof, D., Shlitner, A., Herer, P., Tzischinsky, O., & Lavie, P. (1994) · BMJ · doi:10.1136/bmj.309.6948.167 · Cited by 315
Huedo-Medina, T. B., Kirsch, I., Middlemass, J., Klonizakis, M., & Siriwardena, A. N. (2012) · BMJ · doi:10.1136/bmj.e8343 · Cited by 313
Wang, P. S., Bohn, R. L., Glynn, R. J., Mogun, H., & Avorn, J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.892 · Cited by 312
Galanos, A. N., Pieper, C. F., Cornoni‐Huntley, J. C., Bales, C. W., & Fillenbaum, G. G. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb07483.x · Cited by 311
A Review of the Evidence for the Efficacy and Safety of Trazodone in Insomnia
Mendelson, W. B. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0409 · Cited by 308
Insomnia in the Elderly: Cause, Approach, and Treatment
Kamel, N. S., & Gammack, J. K. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.051 · Cited by 307
Bioavailability of Oral Melatonin in Humans
Waldhauser, F., Waldhauser, M., Lieberman, H. R., Deng, M.-H., Lynch, H. J., & Wurtman, R. J. (1984) · Neuroendocrinology · doi:10.1159/000123997 · Cited by 304
Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials
Herring, W. J., Connor, K. M., Ivgy-May, N., Snyder, E., Liu, K., Snavely, D. B., Krystal, A. D., Walsh, J. K., Benca, R. M., Rosenberg, R., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.10.003 · Cited by 300
Zolpidem: A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Potential
Langtry, H. D., & Benfield, P. (1990) · Drugs · doi:10.2165/00003495-199040020-00008 · Cited by 297
Zaleplon: A Review of its Use in the Treatment of Insomnia
Dooley, M., & Plosker, G. L. (2000) · Drugs · doi:10.2165/00003495-200060020-00014 · Cited by 287
Clinical Pharmacokinetics and Pharmacodynamics of Zolpidem: Therapeutic Implications
Salvà, P., & Costa, J. (1995) · Clinical Pharmacokinetics · doi:10.2165/00003088-199529030-00002 · Cited by 273
Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia
Roth, T., Seiden, D., Sainati, S., Wang-Weigand, S., Zhang, J., & Zee, P. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2006.01.003 · Cited by 265
Drover, D. R. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443040-00002 · Cited by 248
Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia
Weitzel, K. W., Wickman, J. M., Augustin, S. G., & Strom, J. G. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)83024-6 · Cited by 246
Toxicity of high‐dose flurazepam in the elderly
Greenblatt, D. J., Allen, M. D., & Shader, R. I. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1977213355 · Cited by 244
Benzodiazepine Use and Hip Fractures in the Elderly: Who Is at Greatest Risk?
Wagner, A. K., Zhang, F., Soumerai, S. B., Walker, A. M., Gurwitz, J. H., Glynn, R. J., & Ross-Degnan, D. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.14.1567 · Cited by 241
Winkelman, J. W. (2015) · New England Journal of Medicine · doi:10.1056/nejmcp1412740 · Cited by 232
ROTH, T., WALSH, J., KRYSTAL, A., WESSEL, T., & ROEHRS, T. (2005) · Sleep Medicine · doi:10.1016/j.sleep.2005.06.004 · Cited by 230
Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man
Leathwood, P. D., Chauffard, F., Heck, E., & Munoz-Box, R. (1982) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(82)90264-7 · Cited by 229
Effect of Age on EEG Arousals in Normal Sleep
(1998) · Sleep · doi:10.1093/sleep/21.4.361 · Cited by 216
Double-Blind, Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients
Schatzberg, A. F., Kremer, C., Rodrigues, H. E., & Murphy, G. M. (2002) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200209000-00007 · Cited by 215
Safety of mirtazapine: a review
Montgomery, S. A. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199512004-00006 · Cited by 214
Ford, E. S., Wheaton, A. G., Cunningham, T. J., Giles, W. H., Chapman, D. P., & Croft, J. B. (2014) · Sleep · doi:10.5665/sleep.3914 · Cited by 213
Critical Evaluation of the Effect of Valerian Extract on Sleep Structure and Sleep Quality
Donath, F., Quispe, S., Diefenbach, K., Maurer, A., Fietze, I., & Roots, I. (2000) · Pharmacopsychiatry · doi:10.1055/s-2000-7972 · Cited by 209
Victorri‐Vigneau, C., Dailly, E., Veyrac, G., & Jolliet, P. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02861.x · Cited by 201
Gustavsen, I., Bramness, J. G., Skurtveit, S., Engeland, A., Neutel, I., & Mørland, J. (2008) · Sleep Medicine · doi:10.1016/j.sleep.2007.11.011 · Cited by 201
Cognitive and Other Adverse Effects of Diphenhydramine Use in Hospitalized Older Patients
Agostini, J. V., Leo-Summers, L. S., & Inouye, S. K. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.17.2091 · Cited by 197
Evaluation of the Efficacy and Safety of Ramelteon in Subjects with Chronic Insomnia
Zammit, G., Erman, M., Wang-Weigand, S., Sainati, S., Zhang, J., & Roth, T. (2007) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26914 · Cited by 197
Gooneratne, N. S., & Vitiello, M. V. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.04.007 · Cited by 196
Krystal, A. D., Durrence, H. H., Scharf, M., Jochelson, P., Rogowski, R., Ludington, E., & Roth, T. (2010) · Sleep · doi:10.1093/sleep/33.11.1553 · Cited by 193
Morin, C. M., Koetter, U., Bastien, C., Ware, J. C., & Wooten, V. (2005) · Sleep · doi:10.1093/sleep/28.11.1465 · Cited by 190
Age-Related Reduction in the Maximal Capacity for Sleep—Implications for Insomnia
Klerman, E. B., & Dijk, D.-J. (2008) · Current Biology · doi:10.1016/j.cub.2008.06.047 · Cited by 188
Atypical antipsychotics: sleep, sedation, and efficacy.
Miller, D. D. (2004) · PubMed Central · Cited by 184
Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability
Wheatley, D. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105053309 · Cited by 177
Chen, P.-L., Lee, W.-J., Sun, W.-Z., Oyang, Y.-J., & Fuh, J.-L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049113 · Cited by 177
The Relationship between Benzodiazepine Use and Traffic Accidents: A Systematic Literature Review
Smink, B. E., Egberts, A. C. G., Lusthof, K. J., Uges, D. R. A., & de Gier, J. J. (2010) · CNS Drugs · doi:10.2165/11533170-000000000-00000 · Cited by 174
Camargos, E. F., Louzada, L. L., Quintas, J. L., Naves, J. O. S., Louzada, F. M., & Nóbrega, O. T. (2014) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.12.174 · Cited by 170
Saari, T. I., Uusi‐Oukari, M., Ahonen, J., & Olkkola, K. T. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002717 · Cited by 170
The Pharmacology and Mechanisms of Action of New Generation, Non-Benzodiazepine Hypnotic Agents
Sanger, D. J. (2004) · CNS Drugs · doi:10.2165/00023210-200418001-00004 · Cited by 168
Treating insomnia: Current and investigational pharmacological approaches
Ebert, B., Wafford, K. A., & Deacon, S. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.014 · Cited by 166
Winokur, A., DeMartinis, N. A., McNally, D. P., Gary, E. M., Cormier, J. L., & Gary, K. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1013 · Cited by 165
Mayer, G., Wang-Weigand, G., Roth‐Schechter, B. F., Lehmann, R., Staner, C., & Partinen, M. (2009) · SLEEP · doi:10.1093/sleep/32.3.351 · Cited by 165
Melatonin and Melatonergic Drugs on Sleep: Possible Mechanisms of Action
Srinivasan, V., Pandi-Perumal, S. R., Trahkt, I., Spence, D. W., Poeggeler, B., Hardeland, R., & Cardinali, D. P. (2009) · International Journal of Neuroscience · doi:10.1080/00207450802328607 · Cited by 161
Mirtazapine: A Review of its Use in Major Depression and Other Psychiatric Disorders
Croom, K. F., Perry, C. M., & Plosker, G. L. (2009) · CNS Drugs · doi:10.2165/00023210-200923050-00006 · Cited by 158
Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro
Dietz, B. M., Mahady, G. B., Pauli, G. F., & Farnsworth, N. R. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.04.009 · Cited by 157
Long-term use of sedative hypnotics in older patients with insomnia
Ancoli-Israel, S., Richardson, G. S., Mangano, R. M., Jenkins, L., Hall, P., & Jones, W. S. (2005) · Sleep Medicine · doi:10.1016/j.sleep.2004.10.015 · Cited by 154
Holm, K. J., & Markham, A. (1999) · Drugs · doi:10.2165/00003495-199957040-00010 · Cited by 151
Quetiapine for insomnia: A review of the literature
Anderson, S. L., & Griend, J. P. V. (2014) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp130221 · Cited by 150
Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment
Jean‐Louis, G., von Gizycki, H., & Zizi, F. (1998) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1998.tb00557.x · Cited by 149
Ancoli‐Israel, S., Walsh, J. K., Mangano, R. M., & Fujimori, M. (1999) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v01n0404 · Cited by 146
Double-Blind, Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients
Schatzberg, A. F. (2002) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.10.5.541 · Cited by 146
Saletu-Zyhlarz, G. M., Abu‐Bakr, M. H., Anderer, P., Gruber, G., Mandl, M., Strobl, R., Gollner, D., Prause, W., & Saletu, B. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00262-7 · Cited by 145
Trazodone enhances sleep in subjective quality but not in objective duration
Montgomery, I., Oswald, I., Morgan, K., & Adam, K. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb04977.x · Cited by 145
Ringdahl, E. N., Pereira, S. L., & Delzell, J. E. (2004) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.17.3.212 · Cited by 145
Synthesis of a Novel Series of Tricyclic Indan Derivatives as Melatonin Receptor Agonists
Uchikawa, O., FUKATSU, K., Tokunoh, R., Kawada, M., Matsumoto, K., Imai, Y., Hinuma, S., Kato, K., Nishikawa, H., Hirai, K., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0201159 · Cited by 143
A 2-Week Efficacy and Safety Study of Eszopiclone in Elderly Patients with Primary Insomnia
Scharf, M. B., Erman, M. K., Rosenberg, R. P., Seiden, D., McCall, W. V., Amato, D. A., & Wessel, T. C. (2005) · SLEEP · doi:10.1093/sleep/28.6.720 · Cited by 143
Sleep problems in the elderly.
Neubauer, D. N. (1999) · PubMed · Cited by 142
The benefits and risks of ECT for patients with primary dementia who also suffer from depression
Rao, V., & Lyketsos, C. G. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/1099-1166(200008)15:8<704::aid-gps183>3.0.co;2-s · Cited by 141
The effect of age on the pharmacokinetics and pharmacodynamics of midazolam
Albrecht, S., Ihmsen, H., Hering, W., Geißlinger, G., Dingemanse, J., Schwilden, H., & Schüttler, J. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)90084-x · Cited by 141
Krystal, A. D., Lankford, A., Durrence, H. H., Ludington, E. A., Jochelson, P., Rogowski, R., & Roth, T. G. (2011) · SLEEP · doi:10.5665/sleep.1294 · Cited by 141
Melatonin for treatment of sleep disorders.
Buscemi, N., Vandermeer, B., Pandya, R., Hooton, N., Tjosvold, L., Hartling, L., Baker, G., Vohra, S., & Klassen, T. (2004) · Evidence report/technology assessment · doi:10.1037/e439412005-001 · Cited by 139
The medicalization of sleeplessness: a public health concern
Moloney, M. E., Konrad, T. R., & Zimmer, C. R. (2011) · American Journal of Public Health · doi:10.2105/ajph.2010.300014 · Cited by 136
Ramelteon: A Novel Hypnotic Lacking Abuse Liability and Sedative Adverse Effects
Johnson, M. W., Suess, P. E., & Griffiths, R. R. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1149 · Cited by 135
Management of chronic insomnia in elderly persons
Bain, K. T. (2006) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2006.06.006 · Cited by 135
Complementary and Alternative Medicine for Sleep Disturbances in Older Adults
Gooneratne, N. S. (2008) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2007.08.002 · Cited by 133
The effects of trazodone on sleep in patients treated with stimulant antidepressants
Kaynak, H., Kaynak, D., Gözükırmızı, E., & Guilleminault, C. (2003) · Sleep Medicine · doi:10.1016/j.sleep.2003.06.006 · Cited by 133
Karim, A., Tolbert, D. S., & Cao, C. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005283461 · Cited by 133
Otmani, S., Demazières, A., Staner, C., Jacob, N., Nir, T., Zisapel, N., & Staner, L. (2008) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.980 · Cited by 133
Practical Geriatrics: Use of Benzodiazepines Among Elderly Patients
Bogunovic, O. J., & Greenfield, S. F. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.3.233 · Cited by 132
Therapeutic Options for Sleep‐Maintenance and Sleep‐Onset Insomnia
Morin, A. K., Jarvis, C. I., & Lynch, A. M. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.1.89 · Cited by 131
The Effect of Valerian Extract on Sleep Polygraphy in Poor Sleepers: A Pilot Study
Schulz, H. R., Stolz, C., & Müller, J. (1994) · Pharmacopsychiatry · doi:10.1055/s-2007-1014295 · Cited by 129
Understanding the pharmacokinetics of anxiolytic drugs
Altamura, A. C., Moliterno, D., Paletta, S., Maffini, M., Mauri, M. C., & Bareggi, S. R. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.759209 · Cited by 127
Doxepin for insomnia: A systematic review of randomized placebo-controlled trials
Yeung, W.-F., Chung, K.-F., Yung, K.-P., & Ng, T. H.-Y. (2015) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2014.06.001 · Cited by 126
Winokur, A., Sateia, M. J., Hayes, J. B., Bayles-Dazet, W., MacDonald, M. M., & Gary, K. A. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00882-9 · Cited by 123
Diphenhydramine in Insomniac Family Practice Patients: A Double‐Blind Study
Rickels, K., MORRIS, R. J., Newman, H. M., ROSENFELD, H., SCHILLER, H., & Weinstock, R. (1983) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1983.tb02730.x · Cited by 122
History of benzodiazepine dependence
LADER, M. H. (1991) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(91)90027-8 · Cited by 119
Effects of trazodone on the sleep of depressed subjects—a polygraphic study
Mouret, J., Lemoine, P., Minuit, M. P., Benkelfat, C., & Renardet, M. (1988) · Psychopharmacology · doi:10.1007/bf00172629 · Cited by 116
Stranks, E. K., & Crowe, S. F. (2014) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2014.928268 · Cited by 116
Bierman, E. J. M., Comijs, H. C., Gundy, C. M., Sonnenberg, C., Jonker, C., & Beekman, A. T. F. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1811 · Cited by 114
Diagnosis and treatment of insomnia
Passarella, S., & Duong, M.-T. (2008) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060640 · Cited by 111
Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Elderly Patients With Primary Insomnia
Scharf, M. B., Rogowski, R., Hull, S. G., Cohn, M. A., Mayleben, D. W., Feldman, N. T., Ereshefsky, L., Lankford, A., & Roth, T. G. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1005 · Cited by 111
Cognitive, psychomotor and polysomnographic effects of trazodone in primary insomniacs
Roth, A. J., McCall, W. V., & Liguori, A. (2011) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2011.00928.x · Cited by 110
Najib, J. S. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.04.014 · Cited by 110
Effect of the antidepressant Org 3770 on human sleep
Ruigt, G. S. F., Kemp, B., Groenhout, C. M., & Kamphuisen, H. A. C. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00278580 · Cited by 110
Use of pramipexole in REM sleep behavior disorder: Results from a case series
Schmidt, M. H., Koshal, V. B., & Schmidt, H. S. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2006.03.018 · Cited by 110
Zolpidem Use and Risk of Fracture in Elderly Insomnia Patients
Kang, D. Y., Park, S., Rhee, C.-W., Kim, Y., Choi, N., Lee, J., & Park, B. (2012) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.2012.45.4.219 · Cited by 106
Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans
Rush, C. R., Baker, R. W., & Wright, K. (1999) · Psychopharmacology · doi:10.1007/s002130050997 · Cited by 98
A polysomnography study of eszopiclone in elderly patients with insomnia
McCall, W. V., Erman, M. K., Krystal, A. D., Rosenberg, R. P., Scharf, M. B., Zammit, G. K., & Wessel, T. C. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x112741 · Cited by 97
Ancoli-lsrael, S., Krystal, A. D., McCall, W. V., Schaefer, K., Wilson, A., Claus, R., Rubens, R., & Roth, T. G. (2010) · SLEEP · doi:10.1093/sleep/33.2.225 · Cited by 96
(1990) · PubMed · Cited by 95
A double‐blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients
Hsyøerg, O. J., Maragakis, B. P., Mullin, J. M., Norum, D., Stordall, E., Ekdahl, P., Ose, E., Moksnes, K., & Sennef, C. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb10629.x · Cited by 95
H1-receptor antagonists: safety issues
Simons, F. E. (1999) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)62855-4 · Cited by 95
Open pilot study of gabapentin versus trazodone to treat insomnia in alcoholic outpatients
Karam‐Hage, M., & Brower, K. J. (2003) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2003.01161.x · Cited by 95
Walsh, J. K., Deacon, S., Dijk, D., & Lundahl, J. (2007) · SLEEP · doi:10.1093/sleep/30.5.593 · Cited by 95
Org 3770 (mirtazapine) versus trazodone: A placebo controlled trial in depressed elderly patients
Halikas, J. A. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100807 · Cited by 94
GREENBLATT, D., HARMATZ, J., VONMOLTKE, L., WRIGHT, C., & SHADER, R. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.07.009 · Cited by 93
Effects of 2-Week Treatment With Temazepam and Diphenhydramine in Elderly Insomniacs
Glass, J. R., Sproule, B. A., Herrmann, N., & Busto, U. E. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31816a9e4f · Cited by 93
Vural, E. M. S., van Munster, B. C., & de Rooij, S. E. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0178-0 · Cited by 92
Lankford, A., Rogowski, R., Essink, B., Ludington, E. A., Durrence, H. H., & Roth, T. G. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2011.09.006 · Cited by 92
(1990) · PubMed · Cited by 91
Benzodiazepine dependence and withdrawal in elderly patients
Schweizer, E. E., CASE, W. G., & Rickels, K. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.4.529 · Cited by 91
Tariq, S. H., & Pulisetty, S. (2007) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2007.08.009 · Cited by 90
Diaper, A., & Hindmarch, I. (2004) · Phytotherapy Research · doi:10.1002/ptr.1574 · Cited by 89
Changes in Pharmacokinetics and Pharmacodynamics in the Elderly Patient
Hutchison, L. C., & O’Brien, C. E. (2007) · Journal of Pharmacy Practice · doi:10.1177/0897190007304657 · Cited by 89
Rajaratnam, S. M. W., Dijk, D., Middleton, B., Stone, B. M., & Arendt, J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030460 · Cited by 88
Metabolism of Anxiolytics and Hypnotics: Benzodiazepines, Buspirone, Zoplicone, and Zolpidem
Chouinard, G., Lefko-Singh, K., & Teboul, E. (1999) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006943009192 · Cited by 87
Kishi, T., Matsunaga, S., & Iwata, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136910 · Cited by 82
Müller, C. E., Schumacher, B., Brattström, A., Abourashed, E. A., & Koetter, U. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01964-1 · Cited by 82
Use of Non-Benzodiazepine Hypnotics in the Elderly: Are All Agents the Same?
Dolder, C. R., Nelson, M., & McKinsey, J. (2007) · CNS Drugs · doi:10.2165/00023210-200721050-00003 · Cited by 81
Kan, C. C., Hilberink, S. R., & Breteler, M. H. M. (2004) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2003.12.007 · Cited by 81
Understanding the Sleep-Wake Cycle: Sleep, Insomnia, and the Orexin System
Krystal, A. D., Benca, R. M., & Kilduff, T. S. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13011su1c · Cited by 80
Sun, H., Palcza, J. S., Card, D., Gipson, A., Rosenberg, R. P., Kryger, M. H., Lines, C., Wagner, J. A., & Troyer, M. D. (2016) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.5382 · Cited by 80
Feinsilver, S. H. (2003) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(02)00064-2 · Cited by 80
Histamine-1 receptor antagonism for treatment of insomnia
Vande Griend, J. P., & Anderson, S. L. (2012) · Journal of the American Pharmacists Association · doi:10.1331/japha.2012.12051 · Cited by 79
Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal?
Poyares, D. R., Guilleminault, C., Ohayon, M. M., & Tufik, S. B. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00305-0 · Cited by 77
Synaptosomal GABA release as influenced by valerian root extract--involvement of the GABA carrier.
Santos, M. S., Ferreira, F. M. L., da Cunha, A. P., Carvalho, A. P., Ribeiro, C., & Macedo, T. R. A. (1994) · PubMed · Cited by 75
Patel, K. V., Aspesi, A. V., & Evoy, K. E. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015570467 · Cited by 72
Kudo, Y., & Kurihara, M. (1990) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1990.tb03592.x · Cited by 71
Efficacy and Safety of Zolpidem Extended Release in Elderly Primary Insomnia Patients
Walsh, J. K., Soubrane, C., & Roth, T. G. (2007) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181256b01 · Cited by 71
The Influence of Valerian Treatment on 'Reaction Time, Alertness and Concentration' in Volunteers
Kuhlmann, J., Berger, W., Podzuweit, H., & Schmidt, U. (1999) · Pharmacopsychiatry · doi:10.1055/s-2007-991100 · Cited by 68
Melatonin treatment for circadian rhythm sleep disorders
Okawa, M., Uchiyama, M., OZAKI, S., Shibui, K., Kamei, Y., HAYAKAWA, T., & Urata, J. (1998) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1998.tb01063.x · Cited by 68
Effect of Ramelteon on Middle-of-the-Night Balance in Older Adults with Chronic Insomnia
Zammit, G. K., Wang‐Weigand, S., Rosenthal, M. H., & Peng, X. (2009) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27390 · Cited by 68
Suvorexant: First Global Approval
Yang, L. P. H. (2014) · Drugs · doi:10.1007/s40265-014-0294-5 · Cited by 67
Pharmacokinetic and pharmacodynamic characteristics of trazodone in the elderly.
Bayer, A. J., Pathy, M., & Ankier, S. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02180.x · Cited by 65
Greenblatt, D. J., Harmatz, J. S., & Karim, A. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006298602 · Cited by 65
Treatment of insomnia: an alternative approach.
Attele, A. S., Xie, J., & Yuan, C. (2000) · PubMed · Cited by 64
Chronic insomnia: a practical review.
Rajput, V., & Bromley, S. M. (1999) · PubMed · Cited by 59
Efficacy and clinical safety of ramelteon: An evidence-based review
Sateia, M. J., Kirby-Long, P., & Taylor, J. L. (2008) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2007.12.005 · Cited by 59
Long-term use of zolpidem increases the risk of major injury: a population-based cohort study
Lai, M.-M., Lin, C.-C., Lin, C.-C., Liu, C.-S., Li, T.-C., & Kao, C.-H. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.01.021 · Cited by 58
Mirtazapine for Treatment of Depression and Comorbidities in Alzheimer Disease
Raji, M. A., & Brady, S. R. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.10371 · Cited by 52
Eszopiclone: its use in the treatment of insomnia
Monti, J. M., & Pandi-Perumal, S. R. (2007) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a916 · Cited by 50
Melatonin as a Marker and Phase-resetter of Circadian Rhythms in Humans
Lewy, A. J. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46814-x_51 · Cited by 49
Effect of daytime oral melatonin administration on neurobehavioral performance in humans
Rogers, N. L., Phan, O., Kennaway, D. J., & Dawson, D. E. (1998) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1998.tb00385.x · Cited by 49
Clinical distinctions between long-acting and short-acting benzodiazepines.
Mendelson, W. B. (1992) · PubMed · Cited by 48
Timmer, C. J., Paanakker, J. E., & van Hal, H. J. M. (1996) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199611)11:6<497::aid-hup820>3.0.co;2-j · Cited by 48
Evaluation of subjective efficacy and safety of ramelteon in Japanese subjects with chronic insomnia
Uchiyama, M., Hamamura, M., Kuwano, T., Nishiyama, H., Nagata, H., & Uchimura, N. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2010.08.010 · Cited by 45
Furey, S. A., Hull, S. G., Leibowitz, M. T., Jayawardena, S., & Roth, T. G. (2014) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.4110 · Cited by 45
Clinical Pharmacokinetics of Antidepressants in the Elderly: Therapeutic Implications
Moltke, L. L., Greenblatt, D. J., & Shader, R. I. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199324020-00004 · Cited by 44
Melatonin and fragmented sleep patterns
Middleton, B., Stone, B. M., & Arendt, J. (1996) · The Lancet · doi:10.1016/s0140-6736(05)64715-0 · Cited by 44
Balon, R. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000353599 · Cited by 44
Hypnosedatives in the Elderly: A Guide to Appropriate Use
Woodward, M. C. (1999) · CNS Drugs · doi:10.2165/00023210-199911040-00003 · Cited by 42
Retrospective Population Cohort Study on Hip Fracture Risk Associated with Zolpidem Medication
Lin, F.-Y., Chen, P., Liao, C.-H., Hsieh, Y., & Sung, F. (2014) · SLEEP · doi:10.5665/sleep.3566 · Cited by 41
Mini, L. J., Wang‐Weigand, S., & Zhang, J. (2007) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2007.09.004 · Cited by 41
Non–Benzodiazepine Receptor Agonists for Insomnia
Becker, P. M., & Somiah, M. (2014) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2014.11.002 · Cited by 37
Rosenberg, R. P., Hull, S. G., Lankford, D. A., Mayleben, D. W., Seiden, D., Furey, S. A., Jayawardena, S., & Roth, T. G. (2014) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.4108 · Cited by 36
Efficacy and safety of doxepin 6 mg in a model of transient insomnia
Roth, T. G., Durrence, H. H., Jochelson, P., Peterson, G., Ludington, E. A., Rogowski, R., Scharf, M. B., & Lankford, A. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2010.07.006 · Cited by 36
Mashiko, H., Niwa, S., Kumashiro, H., Kaneko, Y., Suzuki, S., Numata, Y., Horikoshi, R., & Watanabe, Y. (1999) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.1999.00532.x · Cited by 35
Use of ultra-low-dose (≤6 mg) doxepin for treatment of insomnia in older people
Rojas‐Fernandez, C. H., & Chen, Y. (2014) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163514543856 · Cited by 32
Stevenson, S. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.11.085 · Cited by 32
An alpha2 adrenoceptor antagonist, Org 3770, enhances nocturnal melatonin secretion in man
Palazidou, E., Papadopoulos, A., Sitsen, A. J. M., Stahl, S. M., & Checkley, S. (1989) · Psychopharmacology · doi:10.1007/bf00443424 · Cited by 32
Eszopiclone for late-life insomnia.
McCrae, C. S., Ross, A., Stripling, A. M., & Dautovich, N. D. (2007) · PubMed Central · Cited by 31
Current Patterns and Future Directions in the Treatment of Insomnia
Winkelman, J. W., & Pies, R. W. (2005) · Annals of Clinical Psychiatry · doi:10.1080/10401230590905344 · Cited by 31
Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications
Greenblatt, D. J., & Zammit, G. K. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.741588 · Cited by 28
Uchimura, N., Ogawa, A., Hamamura, M., Hashimoto, T., Nagata, H., & Uchiyama, M. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.197 · Cited by 27
McEvoy, L. K., Smith, M. E., Fordyce, M., & Gevins, A. S. (2006) · SLEEP · doi:10.1093/sleep/29.7.957 · Cited by 26
Cited by
Shaker, M. S., Wallace, D. V., Golden, D. B. K., Oppenheimer, J., Bernstein, J. A., Campbell, R. L., Dinakar, C., Ellis, A., Greenhawt, M., Khan, D. A., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.01.017 · Cited by 715
Dominguez, L. J., Veronese, N., Vernuccio, L., Catanese, G., Inzerillo, F., Salemi, G., & Barbagallo, M. (2021) · Nutrients · doi:10.3390/nu13114080 · Cited by 433
Rosenberg, R., Murphy, P., Zammit, G., Mayleben, D., Kumar, D., Dhadda, S., Filippov, G., LoPresti, A., & Moline, M. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.18254 · Cited by 412
Sutton, E. L. (2021) · Annals of Internal Medicine · doi:10.7326/aitc202103160 · Cited by 284
Wang, W.-L., Chen, K.-H., Pan, Y.-C., Yang, S.-N., & Chan, Y.-Y. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02566-4 · Cited by 176
Metadata
- Authors
- Schroeck, J. L., Ford, J., Conway, E. L., Kurtzhalts, K. E., Gee, M. E., Vollmer, K. A., & Mergenhagen, K. A.
- Venue
- Clinical Therapeutics
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 38
- Issue
- 11
- Pages
- 2340-2372
- ISSN
- 0149-2918 (ISSN-L)
- OpenAlex
- W2533680877
- Cited by
- 373
- References
- 215
- FWCI
- 42.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.